Board of Directors

Björn Dellgren

Björn Dellgren

Helsingborg, born 1954. Member of the Board since 2008
CEO for Adenovir Pharma AB and Investments at P.U.L.S. AB (Sweden). Former Partner at BankInvest, (Denmark). Previous Director of Business Development at Pharmacia Corporation and various international positions in sales, marketing and business management at Pharmacia and the American pharmaceutical company, Lederle. Previous board member in Cellectis SA, (France), CliniGenetics SA, (France) and CMC Biologics, (Denmark).
 
Göran Hellström

Göran Hellström

Chairman
Helsingborg, born 1958
Chairman of the Board since 2005. CEO and Senior Partner in Navet AB. Chairman of Handelsbanken, Stortorget Helsingborg, Mildef AB, Marianne’s Farm AB, Industrifakta AB and Rögle BK. Board Member in Arenabolaget i Ängelholm AB. Member of the Board in Brinova Fastigheter AB (publ).
 
Svante Paulsson

Svante Paulsson

Ängelholm, born 1972
Member of the Board since 2007. Responsible for Projects and Strategic Affairs in Backahill AB. Board Member in Fabege AB, Bilia AB, Backahill AB, Peab and Rögle BK.
 
Ken Tinebo

Ken Tinebo

Ängelholm, born 1962 
Member of the Board since 2015.
 
Per-Anders Abrahamsson

Per-Anders Abrahamsson

MD, PhD, was appointed as Associate Professor 1989 and Professor 2000 at Lund University. Dr Abrahamsson is also holding a position as Adjunct Professor at the University of Rochester Medical Center, New York, since 1993.

He has been working as a urologist for 40 years, and 20 years as Head of the Department of Urology, Skåne University Hospital. He is currently also acting as Immediate Past Secretary General of the European Association of Urology, and Executive Medical Director at Ferring Pharmaceuticals A/S and Board Member at Camurus AB.

AB CERNELLE • HÖGANÄSVÄGEN 365 • SE-262 94 ÄNGELHOLM • SWEDEN • TEL +46 (0)42 69 230 • This email address is being protected from spambots. You need JavaScript enabled to view it.WWW.CERNELLE.COMSITEMAP